This article has Open Peer Review reports available.
Concurrent colonic mucosa-associated lymphoid tissue lymphoma and adenoma diagnosed after a positive fecal occult blood test: a case report
© Lin et al. 2016
Received: 18 June 2015
Accepted: 14 January 2016
Published: 27 January 2016
Colonic lymphoma is an uncommon presentation of extranodal lymphoma. Colonic mucosa-associated lymphoid tissue lymphoma is a different entity from gastric mucosa-associated lymphoid tissue lymphoma, and very rare. The presentation and management of colonic mucosa-associated lymphoid tissue are highly variable in the literature.
We report the case of a 59-year-old Taiwanese man who underwent a colonoscopy after a positive test for fecal occult blood. His past history included hypertension and hyperthyroidism. The colonoscopy revealed an adenomatous polyp and mucosa-associated lymphoid tissue lymphoma. We successfully performed a polypectomy and endoscopic mucosal resection. The lymphoma was staged according to the Ann Arbor system modified by Musshoff as E-I. Our patient showed no lymphoma recurrence over a 3-year follow-up.
Endoscopic mucosal resection for colonic mucosa-associated lymphoid tissue lymphoma without disseminated disease may be feasible. We successfully used colonoscopic treatment without adjuvant therapy to treat early-stage pathogen-free colonic mucosa-associated lymphoid tissue lymphoma.
The gastrointestinal tract is the most common site for extranodal lymphomas, with the colon being the least involved area [1, 2]. Colon lymphomas account for 15–20 % of gastrointestinal lymphomas , 1.4 % of all non-Hodgkin’s lymphomas , and 1 % of all colorectal malignancies . Mucosa-associated lymphoid tissue (MALT) lymphoma represents the third most common non-Hodgkin’s lymphoma , and one of the two most common types of gastrointestinal non-Hodgkin’s lymphoma . Unlike gastric MALT lymphoma, colonic MALT lymphoma is very rare. The presentation of colonic MALT lymphoma is highly variable, and its management is not clear [6–11]. We treated a male patient with asymptomatic colonic MALT lymphoma, which was successfully resected by colonoscopy.
Our patient was a 59-year-old Taiwanese, well-nourished man with a history of hypertension for 4 years and hyperthyroidism for one more year that were well controlled. He was a heavy smoker (1–2 packs per day) for 30 years, and had only quit for a few months. He had received a lumbar laminectomy to treat spinal stenosis 6 years previously. He had no relevant family history. He had developed thyrotoxic exophthalmos 2–3 months prior to presentation and received steroid pulse therapy for compressive optic neuropathy. The symptoms were relieved for 2–3 months after the steroid therapy.
Our patient was transferred to the hematologist’s clinic, and further studies revealed no disease dissemination. A physical examination revealed no palpable lymph nodes, no petechiae, and no hepatosplenomegaly. A computed tomography scan revealed no metastatic tumors, nor enlarged lymph nodes. A bone marrow biopsy of his right iliac bone revealed small aggregates of small lymphoid cells but an immunohistochemical study did not suggest any MALT lymphoma involvement. An otorhinolaryngologist found no abnormalities in his ear drums, nose, oral cavity, nasopharynx, or vocal cord. The tumor stage was E-I according to the Ann Arbor staging system modified by Musshoff .
Our patient had regular follow-up appointments with the hematologist and proctologist without any signs of lymphoma recurrence for 3 years. Two years after his initial presentation, a colonoscopy revealed a transverse colon adenoma and a rectal hyperplastic polyp. The previous site of the MALT lymphoma was free of tumor, and no other evidence of MALT lymphomas was found. A polypectomy was performed with no unexpected events.
According to his history and throughout his clinical course, our patient had no symptoms or signs of a peptic ulcer. We did not perform a panendoscopy nor test for Helicobacter pylori. There were no other symptoms or signs compatible with autoimmune diseases or viral infection. We did not test for Epstein-Barr virus (EBV). During the last 2 years, he has had no epigastralgia, no acid reflux, and no tarry stool.
MALT-type lymphoma was first defined by Isaacson and Wright in 1983 . Colon lymphoma is a rare example of extranodal lymphoma. Colonic MALT lymphoma is much rarer than gastric MALT lymphoma, which is related to H. pylori infection [1, 2, 9]. MALT development is thought to be related to chronic antigen stimulation . It comprises morphologically heterogeneous small B-cells, and typically infiltrates the epithelium . Colon MALT lymphoma might be a more “benign” disease given that most cases reported in the literature were stage E-I and E-II diseases without dissemination [6–11].
The most well-known gastrointestinal lymphoma is gastric MALT lymphoma. Gastric MALT lymphoma has a strong predisposing factor, H. pylori infection. The prevalence of H. pylori infection is as high as 80 % in patients with gastric MALT lymphoma [15, 16]. However, not all patients are responsive to H. pylori eradication [17, 18]. Furthermore, the recurrence of gastric MALT lymphoma is accompanied by H. pylori infection in only 0–57 % of patients [17, 19]. Asano et al. reviewed H. pylori-negative gastric MALT lymphomas and suggested that possible mechanisms include antibiotic eradication for non-H. pylori bacteria and the immunomodulatory effect of clarithromycin .
Other associated diseases, such as EBV infection and autoimmune diseases, have also been reported in the literature . Kaneko et al. reported the resemblance between tonsil MALT lymphoma and EBV-related tonsillar hyperplasia . These two diseases can only be differentiated by immunohistochemical studies. MALT lymphomas of sites other than the stomach have also been reported. They include lung , tonsil , and ocular adnexa . Most of them these lymphomas had a benign or pre-malignant nature with an excellent prognosis [22, 23].
Unlike gastric MALT lymphoma, colon MALT lymphoma does not have any obvious predisposing factors. Although chronic antigen stimulation is a hypothetical etiology , it was not present in most reported colon MALT lymphomas. Several cases with MALT lymphoma received and responded to H. pylori eradication [7, 10]. Our patient had a history of hyperthyroidism and exophthalmos, but associations between other diseases and colon MALT lymphoma had not been reported in the literature until 2–3 years ago. Jain et al. reported a MALT lymphoma of the cecum presenting as an acute bowel obstruction; however, no H. pylori nor other etiologies could be identified . Terada reported the case of an 18-year-old man with a 2-year history of ulcerative colitis who developed MALT lymphoma . His diagnosis was made by colonoscopic biopsy, and he only received treatment for his ulcerative colitis after that .
The presentation and management of colonic MALT lymphoma are still highly variable. The symptoms include a positive test for fecal occult blood, constipation, abdominal pain, gastro-intestinal bleeding, and tenesmus, or it may be asymptomatic [6–11]. Management includes local resection, colectomy, H. pylori eradication, chemotherapy, and radiotherapy [6–8, 10, 11]. To the best of our knowledge, our patient’s case is the first report of successful management by colonoscopy for MALT lymphoma. No antibiotic eradication was applied. Our patient has one of the longest follow-up times without recurrence (3 years) reported in the literature . However, the rarity of colon MALT lymphomas means that more cases are required for comparison.
Although more and more MALT lymphomas have been reported, colon involvement is still relatively rare. We report the case of a patient with a colonic MALT lymphoma with previous hyperthyroidism. Our patient was asymptomatic and underwent endoscopic mucosal resection without antibiotic eradication for a stage E-I tumor. He attended regular follow-up appointments without lymphoma recurrence for 3 years. A “wait and see” policy for resectable stage E-I colonic MALT lymphoma without pathogens seems to be a reasonable course of action. However, more studies about standard management for the disease are needed.
Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.
We would like to thank the consultants of the Division of Hematology-Oncology, and the Division of Endocrinology and Metabolism, Department of Internal Medicine, Chang Gung Memorial Hospital. We also thank the outstanding team of surgeons and endoscopic therapists of the Division of Colon and Rectal Surgery, Chang Gung Memorial Hospital.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Koch P, del Valle F, Berdel WE, Willich NA, Reers B, Hiddemann W, et al. Primary gastrointestinal non-Hodgkin’s lymphoma: I. Anatomic and histologic distribution, clinical features, and survival data of 371 patients registered in the German Multicenter Study GIT NHL 01/92. J Clin Oncol. 2001;19(18):3861–73.View ArticlePubMedGoogle Scholar
- Psyrri A, Papageorgiou S, Economopoulos T. Primary extranodal lymphomas of stomach: clinical presentation, diagnostic pitfalls and management. Ann Oncol. 2008;19(12):1992–9.View ArticlePubMedPubMed CentralGoogle Scholar
- Doolabh N, Anthony T, Simmang C, Bieligk S, Lee E, Huber P, et al. Primary colonic lymphoma. J Surg Oncol. 2000;74(4):257–62.View ArticlePubMedGoogle Scholar
- Fan CW, Changchien CR, Wang JY, Chen JS, Hsu KC, Tang R, et al. Primary colorectal lymphoma. Dis Colon Rectum. 2000;43(9):1277–82.View ArticlePubMedGoogle Scholar
- Pileri SA, Milani M, Fraternali-Orcioni G, Sabattini E. From the REAL-classification to the upcoming WHO-scheme: a step towards universal categorization of lymphoma’s entities? Ann Oncol. 1998;9(6):607–12.View ArticlePubMedGoogle Scholar
- Schmid C, Vazquez JJ, Diss TC, Isaacson PG. Primary B-cell mucosa-associated lymphoid tissue lymphoma presenting as a solitary colorectal polyp. Histopathology. 1994;24:357–62.View ArticlePubMedGoogle Scholar
- Raderer M, Pfeffel F, Pohl G, Mannhalter C, Valencak J, Chott A. Regression of colonic low grade B cell lymphoma of the mucosa associated lymphoid tissue type after eradication of Helicobacter pylori. Gut. 2000;46:133–5.View ArticlePubMedPubMed CentralGoogle Scholar
- Lee YG, Lee S, Han SW, Lee JS. A case of multiple mucosa-associated lymphoid tissue (MALT) lymphoma of the colon identified as simple mucosal discoloration. J Korean Med Sci. 2005;20(2):325–8.View ArticlePubMedPubMed CentralGoogle Scholar
- Kanneganti K, Bhavna B. Mucosa-associated lymphoid tissue lymphoma presenting as massive gastrointestinal bleeding: a case report. Case Rep Gastroentrol. 2008;2:296–300.View ArticleGoogle Scholar
- Ferreira R, Torres J, Raposo J, Duarte MB, Pereira MJ, Carvalheiro J, et al. Multifocal colonic mucosa-associated lymphoid tissue lymphoma with synchronous tubular adenoma: a coincidental association? Int J Colorectal Dis. 2011;26(9):1221–2.View ArticlePubMedGoogle Scholar
- Akasaka R, Chiba T, Dutta AK, Toya Y, Mizutani T, Shozushima T, et al. Colonic mucosa-associated lymphoid tissue lymphoma. Case Rep Gastroenterol. 2012;6(2):569–75.View ArticlePubMedPubMed CentralGoogle Scholar
- Musshoff K. Clinical staging classification of non-Hodgkin’s lymphomas (author’s transl). Strahlentherapie. 1977;153(5):218–21.PubMedGoogle Scholar
- Isaacson PG, Wright DH. Malignant lymphoma of mucosa-associated lymphoid tissue. A distinctive type of B-cell lymphoma. Cancer. 1983;52:1410–6.View ArticlePubMedGoogle Scholar
- Isaacson PG. Update on MALT lymphomas. Best Pract Res Clin Haematol. 2005;18:57–68.View ArticlePubMedGoogle Scholar
- Asenjo LM, Gisbert JP. Prevalence of Helicobacter pylori infection in gastric MALT lymphoma: a systematic review. Rev Esp Enferm Dig. 2007;99:398–404.View ArticlePubMedGoogle Scholar
- Nakamura S, Yao T, Aoyagi K, Iida M, Fujishima M, Tsuneyoshi M. Helicobacter pylori and primary gastric lymphoma. A histopathologic and immunohistochemical analysis of 237 patients. Cancer. 1997;79:3–11.View ArticlePubMedGoogle Scholar
- Gisbert JP, Calvet X. Review article: common misconceptions in the management of Helicobacter pylori-associated gastric MALT-lymphoma. Aliment Pharmacol Ther. 2011;34(9):1047–62.View ArticlePubMedGoogle Scholar
- Chen LT, Lin JT, Tai JJ, Chen GH, Yeh HZ, Yang SS, et al. Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma. J Natl Cancer Inst. 2005;97:1345–53.View ArticlePubMedGoogle Scholar
- Hong SS, Jung HY, Choi KD, Song HJ, Lee GH, Oh TH, et al. A prospective analysis of low-grade gastric malt lymphoma after Helicobacter pylori eradication. Helicobacter. 2006;11(6):569–73.View ArticlePubMedGoogle Scholar
- Asano N, Iijima K, Koike T, Imatani A, Shimosegawa T. Helicobacter pylori-negative gastric mucosa-associated lymphoid tissue lymphomas: a review. World J Gastroenterol. 2015;21(26):8014–20.View ArticlePubMedPubMed CentralGoogle Scholar
- Kaneko Y, Kojima M, Suzuki S, Takada A, Yamagishi H, Nakazato Y, et al. Atypical interfollicular hyperplasia of tonsils resembling mucosa-associated lymphoid tissue lymphoma: a clinicopathological, immunohistochemical study and Epstein-Barr virus findings in 12 cases. J Clin Exp Hematop. 2014;54(2):111–6.View ArticlePubMedGoogle Scholar
- Rubenstein JN, Beatty C, Kinkade Z, Bryan C, Hogg JP, Gibson LF et al. Extranodal marginal zone lymphoma of the lung: evolution from an underlying reactive lymphoproliferative disorder. J Clin Exp Pathol. 2015;5(1)Google Scholar
- Kiesewetter B, Lukas J, Kuchar A, Mayerhoefer ME, Streubel B, Lagler H, et al. Clinical features, treatment and outcome of mucosa-associated lymphoid tissue (MALT) lymphoma of the ocular adnexa: single center experience of 60 patients. PLoS One. 2014;9(7):e104004.View ArticlePubMedPubMed CentralGoogle Scholar
- Jain V, Misra S, Ahmad F, Rahul K, Singh A. MALT lymphoma of caecum presenting as acute intestinal obstruction: a case report. Indian J Surg. 2013;75 Suppl 1:286–9.View ArticlePubMedGoogle Scholar
- Terada T. Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) in ulcerative colitis. Saudi J Gastroenterol. 2014;20(5):319–22.View ArticlePubMedPubMed CentralGoogle Scholar